HAVN Life Sciences Inc.
CSE: HAVN, 5NP.F
Company Overview
Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.
Financial Highlights
$60,094
Revenue (ttm)
$0
Gross Profit (ttm)
-$0.19
Diluted EPS (ttm)
Management Team
Mr. Tim Moore
CEO & Director
Mr. Gordon Clissold FCGA, FCPA
Chief Financial Officer
Ms. Jenna Pozar
Chief Operations Officer
Dr. Ivan Casselman
Chief Psychedelic Officer
Mr. Alexzander Samuelsson
Chief Research Officer
Mr. Paul More
Controller
Key Highlights
Market Capitalization
$3,371,486
Shares Outstanding
66,771,000
Shares Short (% of Float)
()
Insider Ownership
1%